Cryoport, Inc. (CYRX)
16.81
-0.54
(-3.11%)
USD |
NASDAQ |
Oct 08, 13:23
Cryoport Net Income (Quarterly) : -8.255M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.255M |
| March 31, 2026 | -9.432M |
| December 31, 2025 | -8.521M |
| September 30, 2025 | -6.696M |
| June 30, 2025 | -12.01M |
| March 31, 2025 | -6.738M |
| December 31, 2024 | -17.17M |
| September 30, 2024 | 3.92M |
| June 30, 2024 | -76.42M |
| March 31, 2024 | -15.04M |
| December 31, 2023 | -62.39M |
| September 30, 2023 | -13.27M |
| June 30, 2023 | -18.36M |
| March 31, 2023 | -5.574M |
| December 31, 2022 | -9.436M |
| September 30, 2022 | -5.316M |
| June 30, 2022 | -9.177M |
| March 31, 2022 | -13.40M |
| December 31, 2021 | -260.09M |
| September 30, 2021 | -6.526M |
| June 30, 2021 | -5.389M |
| March 31, 2021 | -3.527M |
| December 31, 2020 | -11.53M |
| September 30, 2020 | -11.42M |
| June 30, 2020 | -5.803M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.943M |
| December 31, 2019 | -0.9475M |
| September 30, 2019 | -12.47M |
| June 30, 2019 | -2.528M |
| March 31, 2019 | -2.387M |
| December 31, 2018 | -2.258M |
| September 30, 2018 | -2.144M |
| June 30, 2018 | -2.471M |
| March 31, 2018 | -2.683M |
| December 31, 2017 | -2.270M |
| September 30, 2017 | -1.980M |
| June 30, 2017 | -1.860M |
| March 31, 2017 | -1.789M |
| December 31, 2016 | -4.284M |
| September 30, 2016 | -2.184M |
| June 30, 2016 | -3.935M |
| March 31, 2016 | -2.710M |
| March 31, 2015 | -1.937M |
| December 31, 2014 | -1.901M |
| September 30, 2014 | -3.112M |
| June 30, 2014 | -3.039M |
| March 31, 2014 | -1.442M |
| December 31, 2013 | -1.840M |
| September 30, 2013 | -14.96M |
| June 30, 2013 | -1.324M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 258.00M |
| Protect Pharmaceutical Corp. | -0.02M |
| Champions Oncology, Inc. | -0.426M |
| Medpace Holdings, Inc. | 121.36M |
| Charles River Laboratories International, Inc. | -0.76M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 48.97M |
| Total Expenses (Quarterly) | 57.23M |
| EPS Diluted (Quarterly) | -0.2033 |
| Enterprise Value | 760.35M |
| Gross Profit Margin (Quarterly) | 39.66% |
| Profit Margin (Quarterly) | -16.86% |
| Earnings Yield | -4.86% |
| Normalized Earnings Yield | -4.893 |